Masimo Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Masimo's inventory turnover ratio sequentially decreased to 1.66 in the first quarter 2026, unsurprisingly, as the Masimo markets continue to deteriorate, and MASI's faces growing challenges to bring down its inventories. Masimo's average inventory processing period in the Apr 04 2026 quarter, has increased to 220 days, from 210 days, in the Jan 03 2026 quarter.

Within Healthcare sector 236 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 1100, from total ranking in the fourth quarter 2025 at 1180.

MASI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Masimo Corp Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MASI Inventory Turnover Ratio	(Apr 04 2026) I. Quarter	(Jan 03 2026) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter	(Mar 29 2025) I. Quarter
Y / Y Inventory Growth	32.8 %	-17.18 %	-40.59 %	-37.91 %	-40.49 %
Y / Y Cost of Sales Growth	10.14 %	-53.5 %	-41.91 %	-43.15 %	-45.02 %
Inventory Turnover Ratio (TTM)	1.66	1.74	2.18	2.12	2.12
MASI's Total Ranking	# 1100	# 1180	# 937	# 1323	# 892
Average inventory processing period	220	210	168	172	172
Seq. Inventory Growth	5.18 %	12.32 %	6.31 %	5.74 %	-34.41 %
Seq. Cost of Sales Growth	-8.43 %	18.57 %	2.19 %	-0.72 %	-61.34 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 106
Healthcare Sector	# 237
Overall Market	# 1100

Inventory Turnover Ratio Statistics
High	Average	Low
5.42	2.95	-0.98
(Mar 30 2019)		(Dec 31 2016)

MASI Company Profile >> Back to MASI Efficiency Comparisons >> Compare MASI Inventory Turnover Ratio to its Competitors

Financial Statements
Masimo's Inventories	$ 400 Millions	Visit MASI's Balance sheet
Masimo's Cost of Revenues TTM	$ 595 Millions	Visit MASI's Income Statement
What are MASI's Sales?		Visit MASI's Sales by Segment

Other Inventory Turnover Ratios
Masimo's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MASI's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MASI's Competitors
Inventory Turnover Ratio for MASI's Suppliers
Inventory Turnover Ratio for MASI's Customers

You may also want to know
MASI's Sales Growth Rates	MASI's Pe Price to earnings ratio	MASI's Receivables Turnover Ratio	MASI's Stock Quote
MASI's Net Income Growth Rates	MASI's Ps Price to Sales ratio	MASI's Sales per Employee	MASI's Asset Turnover Ratio
MASI's Net Margin	MASI's Pb Price to Book ratio	MASI's Financial Strength Ratios	MASI's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Apr 04 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Apr 04 2026	Inventories at quarter ending Apr 04 2026
Novocure Limited	4.08	$ 167.287 Millions	$ 41 Millions
Lifeward ltd	4.08	$ 13.275 Millions	$ 3 Millions
Ge Healthcare Technologies Inc	4.04	$ 9,262.000 Millions	$ 2,294 Millions
Koru Medical Systems Inc	3.99	$ 16.468 Millions	$ 4 Millions
3m Company	3.94	$ 15,087.000 Millions	$ 3,830 Millions
Iridex Corp	3.92	$ 32.247 Millions	$ 8 Millions
Myomo Inc	3.88	$ 14.000 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.84	$ 71.976 Millions	$ 19 Millions
Escalon Medical Corp	3.79	$ 6.698 Millions	$ 2 Millions
Evolus Inc	3.71	$ 103.000 Millions	$ 28 Millions
Abbvie Inc	3.70	$ 18,420.000 Millions	$ 4,975 Millions
Alpha Teknova Inc	3.69	$ 26.248 Millions	$ 7 Millions
Biocryst Pharmaceuticals Inc	3.67	$ 19.884 Millions	$ 5 Millions
Neuraxis Inc	3.61	$ 0.665 Millions	$ 0 Millions
Mirum Pharmaceuticals Inc	3.50	$ 85.221 Millions	$ 24 Millions
Tandem Diabetes Care Inc	3.45	$ 461.746 Millions	$ 134 Millions
Exelixis Inc	3.41	$ 84.478 Millions	$ 25 Millions
Baxter International Inc	3.37	$ 7,911.000 Millions	$ 2,348 Millions
Gilead Sciences Inc	3.36	$ 6,139.000 Millions	$ 1,825 Millions
Maravai Lifesciences Holdings Inc	3.33	$ 143.875 Millions	$ 43 Millions
Intelligent Bio Solutions Inc	3.31	$ 2.064 Millions	$ 1 Millions
Agilent Technologies inc	3.29	$ 3,418.000 Millions	$ 1,038 Millions
Cadre Holdings inc	3.28	$ 372.000 Millions	$ 113 Millions
Solventum Corporation	3.23	$ 3,363.000 Millions	$ 1,042 Millions
Biofrontera Inc	3.22	$ 8.867 Millions	$ 3 Millions
10x Genomics Inc	3.21	$ 193.000 Millions	$ 60 Millions
Iovance Biotherapeutics inc	3.14	$ 165.941 Millions	$ 53 Millions
Lftd Partners Inc	3.12	$ 28.258 Millions	$ 9 Millions
Prestige Consumer Healthcare Inc	3.11	$ 493.000 Millions	$ 159 Millions
Beyond Air Inc	3.07	$ 6.521 Millions	$ 2 Millions

Date modified: 2026-08-30T14:50:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.